Thrifty Banker
  • Politics
  • Business
  • World
  • Investing
  • Politics
  • Business
  • World
  • Investing

Thrifty Banker

Investing

Cardiex Completes HEARTsense Wearable Study and Secures US Wearable Patent

by April 2, 2024
April 2, 2024
Cardiex Completes HEARTsense Wearable Study and Secures US Wearable Patent

CARDIEX Limited (ASX:CDX) (CARDIEX, the Company) is pleased to announce the successful completion of two significant milestones in the commercialization of its wearable biomarker technology.

Successful Completion of HEARTsense Wearable Study.

The Company has successfully completed its primary study validating the use of its SphygmoCor® biomarker technology in wearables by way of a PPG (Photoplethysmogram) sensor (the “HEARTsense Study”). The objective of the HEARTsense Study was to successfully demonstrate the ability to extract vascular biomarkers from a wearable PPG sensor that could previously only be achieved with the Company’s “gold standard” XCEL biometric monitor, and the soon to be released Pulse biometric monitor.

The XCEL biometric monitor is the market leader in measuring central non-invasive vascular biomarkers and is used by all top 20 US hospitals, global pharmaceutical companies (47 clinical trials), research (2300+ research papers), and in specialist clinical practices. The HEARTsense Study showed that that same proprietary XCEL technology can now be ported into a wearable device in a format compatible with commonly used wearable sensor devices.

Completion of the HEARTsense study is also a key step for the Company as it prepares to lodge its FDA submission for clearance of its CONNEQT Band wearable technology in Q1 FY2025, as well as being a key step towards commercialization.

Commenting on the results of the HEARTsense Study, Cardiex CEO Craig Cooper stated:

“This is a significant achievement for the Company as well as being a game changer for the medical technology industry. This is the first time that medical-grade measurements of arterial health, arterial stiffness, and vascular age have been made by way of a finger-based PPG sensor in a wearable; opening the path to commercialization in a number of device formats.

Our technology strategy has always been to produce products that can be deployed in medical and consumer settings for clinics, in the home, and when on-the-go. Importantly, it’s our focus on medical-grade wearable solutions which distinguishes us from other companies. The HEARTsense Study is a strong validation of that strategy as well as being a key step towards FDA clearance of our CONNEQT Band wearable technology.”

Results of the HEARTsense Study are in the process of being submitted for publication in leading peer-reviewed medical and scientific journals.

Click here for the full ASX Release

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
Miramar Resources Limited (ASX: M2R) – Trading Halt
next post
Additional Deeper Targets Identified in Bonito Prospect

Related Posts

What Do Medical Device Companies Do? (Updated 2023)

September 20, 2023

Canada Beats China for Top Spot in Global...

February 13, 2024

American Eagle Intersects 302 Metres of 1.09% Copper...

January 10, 2024

Canada Nickel Announces Exercise of Mann Property Option...

April 23, 2024

Adrian Day: Gold Stock Investors Capitulating, Dramatic Change...

March 12, 2024

Nuclear Fuels Confirms Deeper Mineralization at Kaycee Uranium...

November 30, 2023

Trailbreaker Resources Extends Surficial Gold Signature at Golden...

September 15, 2023

Fortune and Lomiko Receive Critical Minerals Funding from...

May 21, 2024

Quimbaya Gold Announces Annual General Meeting Results and...

April 1, 2025

Proposed Settlement with the Dominican Republic Government

June 4, 2024

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular

    • 1

      Top 10 Countries for Natural Gas Production (Updated 2024)

      April 6, 2024
    • 2

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 3

      Top 10 Uranium-producing Countries (Updated 2024)

      April 18, 2024
    • 4

      A GOP operative accused a monastery of voter fraud. Nuns fought back.

      January 3, 2025
    • 5

      Top 9 Nickel-producing Countries (Updated 2024)

      April 23, 2024
    • 6

      Australian abolitionist, Grace Forrest, receives coveted ‘Freedom from Fear’ award

      April 13, 2024
    • 7

      LME Sanctions on Russian Metal Push Copper, Nickel and Aluminum Prices Higher

      April 17, 2024

    Categories

    • Business (1,028)
    • Investing (2,046)
    • Politics (2,977)
    • Uncategorized (20)
    • World (3,347)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: thriftybanker.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thriftybanker.com | All Rights Reserved